193001-55-7

Basic information

• Product Name: 7-benzyloxy-6-methoxy-4-phenoxyquinazoline
• Synonyms: 7-benzyloxy-6-methoxy-4-phenoxyquinazoline
• CAS NO: 193001-55-7
• Molecular Weight: 358.397
• Mol File: 193001-55-7.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: 7-benzyloxy-6-methoxy-4-phenoxyquinazoline(CAS DataBase Reference)
• NIST Chemistry Reference: 7-benzyloxy-6-methoxy-4-phenoxyquinazoline(193001-55-7)
• EPA Substance Registry System: 7-benzyloxy-6-methoxy-4-phenoxyquinazoline(193001-55-7)

Safety Data

• Hazardous Substances Data: 193001-55-7(Hazardous Substances Data)

Upstream product

• 193001-44-4 7-benzyloxy-4-chloro-6-methoxyquinazoline hydrochloride 
• 108-95-2 phenol 
• 162364-72-9 7-benzyloxy-4-chloro-6-methoxyquinazoline 
• 179688-01-8 7-(benzyloxy)-6-methoxyquinazolin-4(3H)-one 

Downstream Products

• 193001-56-8 7-hydroxy-6-methoxy-4-phenoxyquinazoline 

Relevant articles and documents

Quinazoline derivatives with anti-tumour activity

The invention concerns quinazoline derivatives of Formula I wherein each of m, R1, n, R2 and R3 have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive agent in the containment and/or treatment of solid tumour disease.

Quinazoline derivatives

The invention concerns quinazoline derivatives of Formula I wherein each of m, R1, n, R2 and R3 have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive agent in the containment and/or treatment of solid tumour disease.

QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER

The invention concerns quinazoline derivatives of Formula (I) wherein each of Z, m, R1, n, R3,Z2 and R14 have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive or anti-proliferative agent in the containment and/or treatment of solid tumour disease.